Critical pathways include Wnt signalling regulators like HCFC1, epigenetic modifiers such as DNMT3A, and synaptic plasticity genes including NRXN3—all implicated in CHD-associated NDDs through population genomics [4]. This evidence concerns the gene DNMT3A and coronary artery disorder.